From Episode 350 of the RealTalkMS podcast with John Strum from the National Multiple Sclerosis Society. May 2024There are more than 20 disease-modifying therapies available to treat MS today. Some are considered high-efficacy, some are considered moderately effective, and each has its own risk profile and side effects to consider. So, how do you choose?How much homework should someone living with MS do? Where should you look for reliable information? And what if you and your neurologist don't necessarily agree?Dr. Barbara Giesser joins John Strum of the RealTalkMS podcast from the National Multiple Sclerosis Society to talk about your role when it comes to choosing the right DMT through shared decision-making with your neurologist. An internationally recognized clinician and award-winning educator, Dr. Giesser has specialized in the care of people with multiple sclerosis since 1982, a full decade before there was even a single disease-modifying therapy available to treat MS.Listen to learn more.<a href="https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/multiple-sclerosis/">https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/multiple-sclerosis/</a>Consultation: <a href="https://www.pacificneuroscienceinstitute.org/brain-health/schedule-a-consultation-multiple-sclerosis/">https://www.pacificneuroscienceinstitute.org/brain-health/schedule-a-consultation-multiple-sclerosis/</a>Clinic: 310-582-7613

From Episode 350 of the RealTalkMS podcast with John Strum from the National Multiple Sclerosis Society. May 2024 There are more than 20 disease-modifying therapies available to treat MS today. Some are considered high-efficacy, some are considered moderately effective, and each has its own risk profile and side effects to consider. So, how do you choose? How much homework should someone living with MS do? Where should you look for reliable information? And what if you and your neurologist don't necessarily agree? Dr. Barbara Giesser joins John Strum of the RealTalkMS podcast from the National Multiple Sclerosis Society to talk about your role when it comes to choosing the right DMT through shared decision-making with your neurologist. An internationally recognized clinician and award-winning educator, Dr. Giesser has specialized in the care of people with multiple sclerosis since 1982, a full decade before there was even a single disease-modifying therapy available to treat MS. Listen to learn more. https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/multiple-sclerosis/ Consultation: https://www.pacificneuroscienceinstitute.org/brain-health/schedule-a-consultation-multiple-sclerosis/ Clinic: 310-582-7613

From Episode 350 of the RealTalkMS podcast with John Strum from the National Multiple Sclerosis Society. May 2024There are more than 20 disease-modifying therapies available to treat MS today. Some are considered high-efficacy, some are considered moderately effective, and each has its own risk profile and side effects to consider. So, how do you choose?How much homework should someone living with MS do? Where should you look for reliable information? And what if you and your neurologist don't necessarily agree?Dr. Barbara Giesser joins John Strum of the RealTalkMS podcast from the National Multiple Sclerosis Society to talk about your role when it comes to choosing the right DMT through shared decision-making with your neurologist. An internationally recognized clinician and award-winning educator, Dr. Giesser has specialized in the care of people with multiple sclerosis since 1982, a full decade before there was even a single disease-modifying therapy available to treat MS.Listen to learn more.<a href="https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/multiple-sclerosis/" rel="noopener noreferrer">https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/multiple-sclerosis/</a>Consultation: <a href="https://www.pacificneuroscienceinstitute.org/brain-health/schedule-a-consultation-multiple-sclerosis/" rel="noopener noreferrer">https://www.pacificneuroscienceinstitute.org/brain-health/schedule-a-consultation-multiple-sclerosis/</a>Clinic: 310-582-7613

Choosing Your MS Disease-Modifying Therapy with Dr. Barbara Giesser

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. You’ll go deep into the brain and beyond, exploring the neurological processes and structures that control our health, hormones, behaviors, movements, moods, and emotions. You’ll learn about new therapies that are giving hope for sufferers of the most challenging diseases, and you’ll hear about some habits you can develop to keep your brain in good working order for years to come. We’ll show you why patients from around the world are coming to Pacific Neuroscience Institute for novel treatments that are in many instances, available at few other institutions.

pacificneuro.org  |  (310) 582-7640

Think Neuro’s host is Anthony Effinger, an award-winning journalist who is fascinated with neuroscience and the workings of the brain. Anthony spent 24 years at Bloomberg News, where he covered money and finance, with deep forays into science and health. In 2006, the Association of Health Care Journalists awarded him first prize for Playing the Odds, an in-depth piece on the changing strategies used to treat prostate cancer. These days, he is a staff writer at Willamette Week, a Pulitzer Prize-winning newspaper in Portland, Oregon, where he lives with his wife and two children. He won the 2022 award for health care journalism from the Association of Alternative Newsmedia for his piece on the disproven Covid remedy ivermectin and the anti-vaxx Portland biologist who was its biggest booster.

Science

Medicine

Health & Fitness

Mental Health

Life Sciences

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. You’ll go deep into the brain and beyond, exploring the neurological processes and structures that control our health, hormones, behaviors, movements, moods, and emotions. You’ll learn about new therapies that are giving hope for sufferers of the most challenging diseases, and you’ll hear about some habits you can develop to keep your brain in good working order for years to come. We’ll show you why patients from around the world are coming to Pacific Neuroscience Institute for novel treatments that are in many instances, available at few other institutions. pacificneuro.org | (310) 582-7640 Think Neuro’s host is Anthony Effinger, an award-winning journalist who is fascinated with neuroscience and the workings of the brain. Anthony spent 24 years at Bloomberg News, where he covered money and finance, with deep forays into science and health. In 2006, the Association of Health Care Journalists awarded him first prize for Playing the Odds, an in-depth piece on the changing strategies used to treat prostate cancer. These days, he is a staff writer at Willamette Week, a Pulitzer Prize-winning newspaper in Portland, Oregon, where he lives with his wife and two children. He won the 2022 award for health care journalism from the Association of Alternative Newsmedia for his piece on the disproven Covid remedy ivermectin and the anti-vaxx Portland biologist who was its biggest booster.

Share Choosing Your MS Disease-Modifying Therapy with Dr. Barbara Giesser

Sign up to save your podcasts

Choosing Your MS Disease-Modifying Therapy with Dr. Barbara Giesser

Choosing Your MS Disease-Modifying Therapy with Dr. Barbara Giesser

More shows like Think Neuro

Hidden Brain

NPR News Now

JAMA Clinical Reviews

STEM-Talk

The Daily

Ologies with Alie Ward

Wonder Podcast: Empowering Women Entrepreneurs to Change the World

The Peter Attia Drive

The Zero to Finals Medical Revision Podcast

Metabolic Freedom With Ben Azadi

Consider This from NPR

Huberman Lab

The Ezra Klein Show

The Mel Robbins Podcast

Glioblastoma aka GBM